ELUCIDATE Study Reports Strong FFR-IQ Performance

Data presented at TCT 2026 report strong performance in the “gray zone” for Elucid’s FDA-cleared FFR-IQ. The study also reports the highest sensitivity and specificity among FFR-CT validations.